Launch week offerEnds in00h00m00s
annual Promonthly Pro
Marcello Arca
Full Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (14)
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Background Despite longstanding epidemiologic data on the association between increased serum triglycerides and cardiovascular events, the exact level at which risk begins to rise is unclear. The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension has conceived a protocol aimed at searching for the prognostic cutoff value of triglycerides in predicting cardiovascular events in a large regional‐based Italian cohort. Methods and Results Among 14 189 subjects aged 18 to 95 years followed‐up for 11.2 (5.3–13.2) years, the prognostic cutoff value of triglycerides, able to discriminate combined cardiovascular events, was identified by means of receiver operating characteristic curve. The conventional (150 mg/dL) and the prognostic cutoff values of triglycerides were used as independent predictors in separate multivariable Cox regression models adjusted for age, sex, body mass index, total and high‐density lipoprotein cholesterol, serum uric acid, arterial hypertension, diabetes, chronic renal disease, smoking habit, and use of antihypertensive and lipid‐lowering drugs. During 139 375 person‐years of follow‐up, 1601 participants experienced cardiovascular events. Receiver operating characteristic curve showed that 89 mg/dL (95% CI, 75.8–103.3, sensitivity 76.6, specificity 34.1, P <0.0001) was the prognostic cutoff value for cardiovascular events. Both cutoff values of triglycerides, the conventional and the newly identified, were accepted as multivariate predictors in separate Cox analyses, the hazard ratios being 1.211 (95% CI, 1.063–1.378, P =0.004) and 1.150 (95% CI, 1.021–1.295, P =0.02), respectively. Conclusions Lower (89 mg/dL) than conventional (150 mg/dL) prognostic cutoff value of triglycerides for cardiovascular events does exist and is associated with increased cardiovascular risk in an Italian cohort.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (29)
Tiziana MONTALCINI
Full Professor of Dietetic Science
Università degli Studi Mediterranea di Reggio Calabria
Giuseppe Mandraffino
Associate Professor
University of Messina
Claudio Borghi
University of Bologna
Manuela Casula
University of Milan
Livia Pisciotta
University of Genoa
Dirk Blom
University of Cape Town
Angelina Passaro
University of Ferrara
Robert Hegele
Jacob J. Wolfe Distinguished Medical Research Chair in Human Gene Function
Western University
Guglielmo Beccuti
University of Turin
Tomas Freiberger
Masaryk University
Maria Del Ben
Sapienza University of Rome
MARCO BUCCI
Professore Associato II fascia confermato
Università degli Studi di Napoli Federico II
Pierluigi Russo
Head of the Health Economic Evaluations Office and of the AIFA’s Monitoring Registers Office
Italian Medicines Agency (AIFA)
Simonetta Genovesi
-
Carmine Izzo
Permanent Cardiologist Medical Director
Università degli Studi di Napoli Federico II
Lorenzo Iughetti
University of Modena and Reggio Emilia
Mariko Harada-Shiba
Proffessor
-
Patrizia Tarugi
Full Professor of General Pathology
Università degli Studi di Modena e Reggio Emilia - Sede di Reggio Emilia
P. Barton Duell
Professor of Medicine
Oregon Health & Science University
Roberto Scicali
Rtdb meds-05/A
University of Catania
Alberico Luigi Catapano
Full Professor
University of Milan
Marina Cuchel
PI
University of Pennsylvania
Paolo Calabrò
University of Campania “Luigi Vanvitelli”
Anna Solini
University of Pisa
Kausik Ray
Professor of Public Health
Imperial College London
Angelo Baldassare Cefalu'
Professor of Internal Medicine
University of Palermo
Sebastiano Calandra
Emeritus Professor of General Pathology
University of Modena and Reggio Emilia
Sandro Muntoni
professor
University of Cagliari
Maria Donata Di Taranto
Associate professor of Clinical Biochemistry and Clinical Molecular Biology
Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche
Make your next move.
Prepare your application
Review drafts before you send them.